»
Renal Disease in Cancer Patients
 
 

Renal Disease in Cancer Patients, 1st Edition

 
Renal Disease in Cancer Patients, 1st Edition,Kevin Finkel,Scott Howard,ISBN9780124159488
 
 
 

Finkel   &   Howard   

Academic Press

9780124159488

9780123982537

312

235 X 191

First translational reference on the diagnosis, management, and treatment of renal disease in cancer patients

Print Book + eBook

USD 155.94
USD 259.90

Buy both together and save 40%

Print Book

Hardcover

In Stock

Estimated Delivery Time
USD 129.95

eBook
eBook Overview

VST format:

DRM Free included formats: EPub, Mobi, PDF

USD 129.95
Add to Cart
 
 

Key Features

  • Covers clinical description, diagnostics, management, and treatment throughout along with genetics, animal models, and pathology in specific chapters
  • Summarizes all renal diseases unique to cancer patients in a single reference
  • Provides a resource for oncologists and nephrologists, as well as general internal and family medicine practitioners, and physicians in training

Description

Renal Disease in Cancer Patients is a translational reference detailing the nephrological problems unique to patients with cancer in an organized and authoritative fashion. This book provides a common language for nephrologists, oncologists, hematologists, and other clinicians who treat cancer patients, to discuss the development of renal diseases in the context of cancer and options for their optimum diagnosis, management, and treatment.

With the advent of better supportive care and the era of personalized medicine, patients with cancer are living longer, and oncologists and nephrologists now recognize the serious consequences of renal disease among these patients.  Designed especially with this new need in mind, Renal Disease in Cancer Patients presents the various renal diseases affecting cancer patients in a single, authoritative volume. The book covers topics in radiation nephritis, obstructive nephropathy, drug nephropathy, graft-versus-host disease, and more.

Readership

Practicing clinicians, fellows, and residents in oncology, hematology, and nephrology

Kevin Finkel

Affiliations and Expertise

Professor and Clinical Vice-Chairman of Medicine; Director, Division of Renal Diseases & Hypertension; Chief, Section of Critical Care Nephrology, University of Texas Medical School, Houston, TX, USA

Scott Howard

Affiliations and Expertise

Associate Member, St. Jude Faculty, Medical Information Officer; Director of Clinical Trials, International Outreach Program, Division of Leukemia/Lymphoma, St. Jude’s Children’s Research Hospital, Memphis, TN, USA

Renal Disease in Cancer Patients, 1st Edition

1. Introduction

  Scott C. Howard and Kevin W. Finkel

2. Acute Kidney Injury

  Joseph R. Angelo and Joshua A. Samuels

3. Biomarkers in Oncology and Nephrology

  Putao Cen, Carl Walther, Kevin W. Finkel, Robert Amato

4. Tumor Lysis Syndrome

  Scott C. Howard, Ching-Hon Pui, Raul C. Ribeiro

5. Multiple Myeloma

  Amit Lahoti

6. Bone Marrow Transplantation

  Benjamin Laskin and Sangeeta Hingorani

7. Radiation Nephritis

  Amber S. Podoll, Mark J. Amsburgh

8. Renal Cell Carcinoma

  Robert Amato

9. Renal Cancer in Children

  Jeffrey S. Dome and Kelly L. Vallance

10. Lymphoma/Leukemia

  Kevin Finkel

11. Electrolyte Disorders

  Abdulla Salahudeen

12. Infections

  Brett W. Stephens

13. Drug Nephropathies

  Ilya Glezerman

14. Paraneoplastic Glomerulonephritis

  Sheron Latcha and Surya V. Seshan

15. Dosing Chemo on RRT

  William H. Fissell IV

16. Cancer after Renal Transplantation

  Horacio Adrogue and Aleksandra Maria De Golovine

Quotes and reviews

"…a translational reference detailing the nephrological problems that cancer patients face...provides a common language for nephrologists, oncologists, hematologists, and other clinicians who treat cancer patients, to discuss the development of renal diseases in the context of cancer and options for their optimum diagnosis, management, and treatment."--Anticancer Research 34, 2014
"This is a useful and up-to-date review of key areas of nephrology in cancer patients that focuses on clinical considerations…It will probably get the most use from consulting nephrologists, oncologists, and pharmacologists specifically trained in advanced cancer protocols, including stem cell transplant." Rating: 3 Stars--Doody.com, May 22, 2014

 
 
Back To School Sale | Use Promo Code BTS14
Shop with Confidence

Free Shipping around the world
▪ Broad range of products
▪ 30 days return policy
FAQ